I-DUBLIN, Juni 26, 2023- Bika "Imakethe Yezidakamizwa Ye-Peptide Ekhawulelwe - Ukuhlaziywa Kwembulunga Yonke Nesifunda: Gxila Ezinhlotsheni Ze-Peptide, Imikhiqizo Nokuhlaziywa Kwesifunda - Ukuhlaziywa Nokubikezelwa, 2024-2040".
Ngemuva kokwethulwa kwemakethe kokuqala komuthi we-peptide onemikhawulo, imakethe yezidakamizwa ekhawulelwe emhlabeni wonke kulindeleke ukuthi ikhule isuka ku-2024 iye ku-2040. Usayizi wemakethe kulindeleke ukuthi ufinyelele ku-$60M ngo-2024 kanye no-$17.38B ngo-2040, nge-CAGR engu-38.94% ngaphezu isikhathi sokubikezela 2025-2040.
Imakethe yezidakamizwa ze-peptide ekhawulelwe emhlabeni wonke kulindeleke ukuthi ibe nokukhula okukhulu ngesikhathi sokubikezela kusuka ngo-2025 kuya ku-2040, okuqhutshwa ingxenye enkulu yisithembiso sokuphumelela okusha kwepayipi le-peptide elikhawulelwe elingasanqunyelwe kokuhlosiwe kwama-receptor.Intuthuko kubuchwepheshe bamakhemikhali, intuthuko ekuhwebeni kwezokwelapha zokwenziwa ze-peptide eminyakeni yamuva nje, kanye namanani angabizi atholwe yilawa ma-biomolecules ezifweni ezihlukahlukene ngezinye zezinto ezengeziwe ezinomthelela ekukhuleni okubikezelwe esikhathini sokubikezela.
Ukuhlaziywa kwemithelela yesikhathi esifushane neyesikhathi eside kwenziwa ezintweni ezithinta kakhulu imakethe, okungukuthi, abashayeli, izithiyo namathuba.Ukuhlola kwesikhathi esifushane kucabangela isikhathi sika-2020-2025 futhi ukuhlola kwesikhathi eside kucabangela isikhathi sika-2026-2040.
Intuthuko esemqoka namasu amukelwe abanye babadlali ababalulekile kule makethe afakiwe ekuhlolweni kokuhlaziywa komthelela.Ngaphezu kwalokho, lezi ntuthuko ezibalulekile ziyahlolwa ukuze kuqondwe amathuba esikhathi esizayo okuhlanganisa ubuchwepheshe obuthuthukisiwe ukuze kuzuzwe imiphumela ephakeme.Ngaphezu kwalokho, ukugunyazwa nokwethulwa kwezinkampani nama-ejensi wamalungelo obunikazi nakho kuyabhekwa lapho kuhlolwa amandla emakethe yomhlaba wonke yemithi ye-peptide ekhawulelwe yi-peptide.
I-Demand Factors and Constraints Okulandelayo yizici zesidingo semakethe ye-Peptide Dependence Inhibitors yomhlaba wonke:
4 Uhlolojikelele lwemakethe 4.1 Isingeniso 4.1.1 Isakhiwo Nokuklanywa Kwama-Peptides Akhawulelwe 4.1.2 Izinhlobo Zama-Peptides Akhawulelwe 4.2 Ukuvela Kwama-Peptides Alinganiselwe 4.3 Ukuthuthukiswa Kwama-Peptides Akhawulelwe Njengezidakamizwa 4.4 Izindawo Zokwelapha Ezingaba Khona 4.5 Izifunda Ezibalulekile 6 I-Value Chain 4 ) ) 4.7 Amathrendi embonini abalulekile endleleni yesingeniso 4.8 Amathrendi abalulekile embonini - inqubekelaphambili yezobuchwepheshe 4.9 Ubukhulu bemakethe yamanje namandla okukhula, i-USD bhiliyoni, 2024-2040 kanye nokuvuselelwa kwezinkampani ezikhiqiza imithi ye-peptide ekhawulelwe
5 Izakhiwo zama-peptide akhawulelwe ngokuhambisana 5.1 Izakhiwo zama-peptide akhawulelwe ngokuhambisana 5.2 Ukuhlanganiswa kwama-peptide akhawulelwe 5.2.1 Ukuxhunyaniswa kwekhemikhali kwama-peptide nokuhlanganisa 5.2.2 Ukuxhunywa kwamakhemikhali ama-peptide ezikalini (CLIPS) 5.2.3 I-Crosslinking ye-peptide ye-peptide. ukutholakala (5.2.5 Liquid-Phase Peptide Synthesis (LPPS) 5.2.6 Solid-Phase Peptide Synthesis (SPPS) 5.3 Advances in Peptide Technology 5.3.1 Peptide Synthesis Ukusebenzisa I-Microfluidics 5.3.2 Solid-Phase Peptide Synthesis (SPPS) Khetha Isistimu
6 Idatha Yemboni 6.1 Uhlolojikelele 6.2 Izinkinga Ezigunyazwe Ngokulawula Izindlela Zama-Peptide Akhawulelwe 6.3 Izimo Ezilawulayo Zama-Peptides Akhawulelwe 6.4 Izidingo Zokulawula Nesakhiwo Sase-US 6.4.1 Ukugunyazwa Kwesivivinyo Semitholampilo 6.4.2 Ngemva kokugunyazwa kwe-FDA.6 Ukugunyazwa kwe-FDA4. umthetho 6.5 Izimfuneko zomthetho zaseYurophu kanye nohlaka 6.5.1 Inqubo yokufaka isicelo selayisensi ye-EMA 6.5.2 Izinqubo ezibekwe endaweni eyodwa 6.5.3 Izinqubo zokwahlukanisa 6.5.4 Izinqubo zokuqashelwa okufanayo 6.5.5 Izinqubo zikazwelonke 6.6 Izidingo zomthetho nezinhlaka esifundeni sase-Asia -Pacific 6.6.1 Izidingo zomthetho kanye nesakhiwo e-Japan 6.7 Izimo zembuyiselo 6.7.1 Izimo zembuyiselo yesifo sokuzivikela komzimba 6.7.2 Izimo zembuyiselo yomdlavuza 6.7.3 Izimo zembuyiselo yezifo ezingavamile
7 I-Market Dynamics 7.1 Ukuhlaziywa Komthelela 7.2 Izici Zemakethe 7.2.1 Ukwenyuswa Kwesibopho Esibophezelayo kanye Nokusebenzisa Amaselula 7.2.2 Ukuthuthukiswa Kwezindlela Zokwenziwa Ezilinganiselwe 7.2.3 Imikhawulo Yama-Peptides Avamile 7.2.4 Ukunyuka Kwezimali Zomphakathi Nezizimele 2 Izimali Zezinkampani Ezizimele 7.2. .4 .2 Ukuxhaswa ngezimali yizinkampani ezisohlwini 7.2.4.3 Ukuxhaswa ngezimali yizikhungo zikahulumeni 7.3 Izingqinamba zezimakethe 7.3.1 Ukwanda kokuncintisana ngesayensi yezinto eziphilayo 7.3.2 Ubungozi bemiphumela yamasosha omzimba kanye nezakhiwo ezingcono kakhulu ze-ADME 7.4 Amathuba ezimakethe 7.4.1 Ama-peptide amancane ekutholakaleni kwezidakamizwa 7.4.2 Izicelo ezihlukahlukene isimiso sezinzwa kanye therapy umdlavuza
8 Isimo sokuncintisana 8.1 Isifinyezo sendawo enokuncintisana 8.1.1 Intuthuko esemqoka 8.1.2 Imisebenzi yokulawula nezomthetho 8.1.3 Ukuhlanganiswa nokutholwa 8.1.4 Imisebenzi yokuhlangana 8.1.5 Imisebenzi yezezimali 8.1.6 Ukuthuthukiswa komtholampilo
9 Imakethe yomhlaba wonke yemithi ye-peptide evimbelayo (ngeziqondiso), mln USD, 2024–2040 9.1 Idizayini Yokuhlolwa Komtholampilo Yokuvimbela Imithi Ye-Peptide 9.1.1 Imithi Yokwelapha Yesigaba II Engaba Khona) 9.1.2.3 Ukusebenza, Ukuphepha, kanye Nedatha Yokubekezelela (Isigaba 1) 9. .2.4 Izifundo Ezingezona Ezomtholampilo Ze-BT5528 9.1.3 PN-9439.1.3.1 Isingeniso Somkhiqizo 9.1.3.2 Ucwaningo lokuklama (Isigaba 2) 9.1.3.3 Ukusebenza kahle, ukuphepha kanye nedatha yokubekezelelana (Isigaba II) 9.1.4 I-PN-2319.1.4 Isingeniso se-PN-2319.1.4. 4.2 Umklamo wocwaningo (Isigaba IIb) 9.1.4.3 Ukusebenza kahle, ukuphepha kanye nedatha yokubekezelelana (Isigaba IIb) 9.1.5 Rusfertide (PTG-300) 9.1.5.1 Uhlolojikelele lomkhiqizo 9.1.5.2 Umklamo wocwaningo (Isigaba II) 9.1.5.3 Ukusebenza kahle, ukuphepha kanye nokuphepha kanye idatha yokubekezelelana (Isigaba IIa) 9.1.6 Izidakamizwa ezingase zibe khona zeSigaba III 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Uhlolojikelele lomkhiqizo 9.1.7.2 Umklamo wocwaningo (Isigaba III) 9.1.7.3 Ukusebenza kahle, ukuphepha kanye nedatha yokubekezelelana (Isigaba III.7.7.) 49. Iphrofayili ye-Pharmacokinetic kanye ne-pharmacodynamic ye-Zilucoplan (Isigaba I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Uhlolojikelele lomkhiqizo 9.1.8.2 Umklamo wocwaningo (Isigaba III) 9.1.8.3 Ukusebenza, ukuphepha kanye nedatha yokubekezelelana (Isigaba II) 9.2 Ukuhlaziywa kwe-9.2 ukuthuthukiswa kwamandla emakethe yomhlaba wonke yemithi ye-peptide ekhawulelwe, i-USD million, impumelelo ka-2024-2040 9.2.2.2 Izindleko zokukhiqizwa kwe-API (CDMO)
10 Imakethe yomhlaba wonke yezidakamizwa ezinesenzo se-peptide esilinganiselwe (ngohlobo lwe-peptide), US$ mln, 2024–2040 peptide exhunyiwe (DRP))
11 Imakethe yomhlaba wonke yemithi ye-peptide ekhawulelwe (ngemikhiqizo engaba khona), i-miln USD, 2024–2040 (RA101495) 11.1.2.1 ukukhiqizwa kwe-API (yasekhaya) 11.1.2.2 Isibikezelo sesidingo se-API sika-2024-2040 11.1.3 Rusfertide-1010 (PTG-301) .3.1 Ukukhiqizwa Kwe-API (Ukukhipha) Izindleko 11.1.4 PN-94311.1.4.1 Ukukhiqizwa Kwe-API (Ukukhipha) 11.1.4.2 I-API Demand Forecast 2024-2040
Isikhathi sokuthumela: Jul-06-2023